Exploring the causal relationship between plasma proteins and postherpetic neuralgia: a Mendelian randomization study

Area of Science:

• Genetics and Proteomics
• Neurology and Pain Research

Background:

• The proteome offers insights into neurological disorder mechanisms and therapeutic targets.
• Investigating plasma protein associations with postherpetic neuralgia (PHN) is crucial for understanding its pathophysiology.

Purpose of the Study:

• To explore potential causal links between plasma proteins and PHN using a two-sample Mendelian randomization approach.
• To identify specific plasma proteins that may serve as diagnostic biomarkers or therapeutic targets for PHN.

Main Methods:

• Utilized genome-wide association study (GWAS) summary statistics from large-scale datasets (Decode Genetics, FinnGen).
• Employed two-sample Mendelian randomization (MR) with various statistical methods (IVW, MR-Egger, etc.) to assess causality.
• Conducted sensitivity and colocalization analyses to ensure result validity and rule out confounding factors like genetic pleiotropy.

Main Results:

• Identified eight plasma proteins significantly associated with PHN risk (PFDR < 0.05).
• ATRN, PIANP, and CD48 levels correlated with increased PHN risk.
• KIR2DL5A, GPI, SEMG2, EIF4B, and HFE2 levels were associated with decreased PHN risk, with robust findings from sensitivity analyses.

Conclusions:

• Suggests a potential causal role for eight plasma proteins in PHN pathogenesis.
• These proteins represent potential candidates for PHN biomarkers and therapeutic interventions.
• The study enhances understanding of PHN pathophysiology, paving the way for future diagnostic and therapeutic strategies.